Merck Q2 Revenue Tops Estimates, Acquisition Charges Drive Adjusted Loss and EPS Guidance Cut

SentiSense · Published · Updated

Merck & Co. (MRK) posted Q2 2026 revenue of $16.61 billion, up 5.1% year over year and above the $16.37 billion consensus. Adjusted results were a $0....

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis